I think it's fairly obvious that we are at a turning point
I think it's fairly obvious that we are at a turning point with Covid. Variants are spreading everywhere, even double variants now, and people infected with more than one kind of covid at the same time! The P1 variant from Brazil is taking over in Canada and has been found in at least half of the U.S. states. The vaccines will not be effective on these variants, meanwhile the U.S. parties and protests on without a care in the world.
So far, the U.S. has pushed their vaccine program at the expense of therapeutics. They have given big pharma millions and millions of dollars, and one by one their drugs have failed. Fauci's darling Remdesivir is doing more harm than good, but still NIH keeps trialing it with everything under the sun. Remember AZT anyone?
Leronlimab is proven safe, and other countries will soon realize they have nothing to lose using it on their critical patients. It's only a matter of time before Leronlimab patients start walking out of ICU's and telling their stories. But those patients won't be Americans, they will come from countries with socialized medicine and universal health care, where big pharma doesn't control the media coverage, where every other ad on the television isn't for a big pharma drug with a list of side effects a mile long.
I don't know how many recovered patients will be necessary to usurp Remdesivir as standard of care here in the U.S. Perhaps someone should ask the eight plus FDA officials with ties to Gilead? But I'm very, very happy to be invest in this company, because Leronlimab is truly remarkable and I know it will be saving lives somewhere soon.
19
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...
Continue Reading
Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...
Continue Reading
The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...
Continue Reading
The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...
Continue Reading
Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...
Continue Reading
Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...
Continue Reading
Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...
Continue Reading
Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...
Continue Reading
Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...
Continue Reading
Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...
Continue Reading
Top 5 Most Recently Viewed Articles
Uber's Position in Autonomous Driving Technology Gary Black, Managing Director of The Future Fund LLC, shares insights on Uber Technologies Inc. (NYSE: UBER) and the evolving landscape of autonomous driving technology. He believes that as automated driving continues to advance, Uber stands to benefit more than any other ride-hailing company in the market. Understanding...
Continue Reading
Gilat Satellite Networks Captures Significant Orders for Connectivity Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a leader in satellite networking technology, has made news by securing more than $18 million in new orders specifically for its in-flight connectivity (IFC) solutions. This impressive achievement underscores the increasing demand for quality...
Continue Reading
A Wine Festival Tradition in Eastern China A captivating wine-themed cultural festival took place in Mengshan Town, Shanggao County, aiming to uplift the local wine industry. This annual event draws visitors from various regions, uniting them in a shared love for fine wines and cultural experiences. The air was filled with excitement as participants engaged in thrilling...
Continue Reading
Understanding Recent Transactions at Danske Bank A/S Danske Bank A/S has been actively engaging in its share buy-back program, as evident from its latest managerial transactions. This initiative allows shareholders greater confidence and highlights the bank's proactive approach in strengthening its share value. Significance of Managerial Transactions Transactions carried...
Continue Reading
Opus Technologies Forms Strategic Alliance for Payment Solutions Opus Technologies has just unveiled a major strategic partnership with a leading company in payment solutions. This collaboration is focused on enhancing payment network compliance solutions for clients who navigate an increasingly regulated landscape. The Power of Synergy This alliance between Opus...
Continue Reading